I need rapid, actionable genomic testing without the data analysis bottlenecks.

Fabric Genomics’ AI-driven software platform enables clinical labs to uncover critical and timely genomic insights that reduce costs and save lives

See how Fabric Genomics impacts healthcare

Speeding up diagnostics across key clinical applications


Diagnostic Odyssey

Combine genotype and phenotype data to identify and prioritize rare disease-causing variants using machine learning



Accelerate analysis to deliver timely, critical diagnoses for acutely ill infants


Hereditary Panels

Leverage AI and a proprietary variant database to generate customized hereditary reports


Oncology Panels

Match cancer variants with treatments and clinical trials for physician-ready oncology reports

You're in good company

Genomics England Logo
LabCorp Logo

Hospitals need to diagnose life-threatening genetic illnesses quickly and efficient. NGS data interpretation is a critical bottleneck.

Every minute counts

In genomic testing applications, such as pediatrics, rare disease diagnosis, and oncology, time is of the essence. The sooner you can detect a problem, the more likely you’ll be able to stop it before it’s too late.

The cost of delayed detection

Slow turnaround times and diagnostic yields can have grave consequences. Undetected genetic illnesses lead to poor outcomes for your patients and substantial healthcare costs.


Powered by AI, Fabric Enterprise enables clinical genomic testing at scale for faster diagnosis and treatment


Undiagnosed genetic illnesses have significant costs for both patients and providers. Fabric Enterprise enables labs to achieve the highest diagnostic yield and the fastest turn-around times to improve patient outcomes and reduce healthcare costs.

One platform. Any test.

Leverage a single comprehensive platform to analyze any NGS test — genomes, exomes, and panels.

Automated workflows.

Reduce turn-around time and labor costs with streamlined workflows for annotating, interpreting, reporting generation, and sign-off

Higher diagnostic yields.

Identify the causative variant quickly and accurately with diagnostic yields of up to 50%, versus industry average of 25-30%

Sequence to physician-ready reports.

Deliver customizable clinical reports ready to sign out in less than 2hrs for whole genome tests.

Ready to get started?

Company updates


Watch Now: Applying Artificial Intelligence to Accelerate Variant Classification and Clinical Reporting of NGS Gene Panels

Watch the talk by Francisco De La Vega to see how panel testing with Fabric ACE enables clinical labs to perform rapid genomic interpretation to uncover critical insights that reduce costs and save lives.

Posted in News | Leave a comment

Pathway to Success with Next Generation Sequencing- Reimbursement Insight and IT Strategies

Labs from every sector- private, reference, hospital, and academic- may be considering expansion of their test offering to include next generation sequencing (NGS). However, before implementing NGS, there are a number of factors that lab leaders must carefully consider to ensure that successful implementation and sustainability of their NGS program. Join XIFIN and Fabric Genomics …

Posted in Webinar | Leave a comment

Fabric Genomics and XIFIN Partner to Expand Access to Clinical Genomics

Clinical genomic testing and next-generation sequencing (NGS) are integral parts of realizing the potential of precision medicine, but the data complexity and technical integrations needed to make genomic data clinically meaningful and routinized have slowed mainstream adoption of these breakthrough technologies. Today, Fabric Genomics, a global leader in clinical interpretation of genomic data, announced a distribution agreement with XIFIN, a …

Posted in Press | Leave a comment

Stay in the loop

Follow us on social media for updates.

Fabric Genomics on LinkedIn
Fabric Genomics on Twitter